ALPS Advisors »

Aerovate Therapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $424k 19k 22.63
2023-09-30 $277k 20k 13.57
2023-06-30 $314k 18k 17.15
2023-03-31 $327k 16k 20.17
2022-12-31 $489k 17k 29.30